Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

Lazzaro, C.; van Steen, C.; Billeit, S.; Frauenknecht, H.; Kallen, C.; Pfennigsdorf, S.; Thelen, U.; Angelillo, L.

2022
Clinical Ophthalmology

Therapeutic Area

Glaucoma

Affiliations

Health Economist and Research Director, Studio di Economia Sanitaria, Milan, Italy; Santen GmbH, München, Germany; Private Practicing Ophthalmologist, Lübeck, Germany; Private Practicing Ophthalmologist, Treuchtlingen, Germany; Private Practicing Ophthalmologist, Krefeld, Germany; Private Practicing Ophthalmologist, Polch, Germany; Private Practicing Ophthalmologist, Münster, Germany; University Hospital Muenster, Department of Ophthalmology, Münster, Germany

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.

Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.

View all Glaucoma publications